|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-2.14/-1.84
|
企业价值
683.40M
|
资产负债 |
每股账面净值
14.58
|
现金流量 |
现金流量率
0.02
|
损益表 |
收益
219.79M
|
每股收益
6.95
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/13 14:47 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. |